Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> JOHNSON & JOHNSON Latest News

FEB 05, 2016 - Wall Street Journal

A Must Read - Share

J&J, AbbVie Shares Drop on Potential Drug Competition

Shares of AbbVie and Johnson & Johnson took a hit Friday after FDA briefing documents hinted a cheaper competitor for the drug companies’ blockbuster anti-inflammatory treatments could be headed to market soon.

Tags: J&J, AbbVie Shares Drop on Potential Drug Competition,  Johnson & Johnson Latest News

FEB 05, 2016 - MarketWatch

A Must Read - Share

Johnson & Johnson shares fall 1.8% to lead Dow decliners in early trade

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Tags: Johnson & Johnson shares fall 1.8% to lead Dow decliners in early trade,  Johnson & Johnson Latest News

FEB 04, 2016 - Philadelphia Inquirer

A Must Read - Share

Johnson & Johnson, ViaCyte testing possible diabetes cure

Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix the life-threatening hormonal disorder.

Tags: Johnson & Johnson, ViaCyte testing possible diabetes cure,  Johnson & Johnson Latest News

FEB 02, 2016 - CNN/Fortune magazine

A Must Read - Share

Oil crash could kill Exxon's perfect AAA rating

Only three American companies can brag of a higher credit rating than the United States government: ExxonMobil, Microsoft and Johnson & Johnson.

Tags: Oil crash could kill Exxon's perfect AAA rating,  Johnson & Johnson Latest News

FEB 02, 2016 - Reuters

A Must Read - Share

GSK and J&J back $1 billion biotech spin-off from Index Ventures

LONDON (Reuters) - Index Ventures, an early investor in technology hits like Skype and Dropbox, is spinning off its biotech portfolio into a new $1 billion (695 million pounds) business, with backing from drug giants GlaxoSmithKline and Johnson & Johnson .

Tags: GSK and J&J back $1 billion biotech spin-off from Index Ventures,  Johnson & Johnson Latest News